Cochrane Review Finds NPH Equal to Lantus and Levemir for type 2’s


By: Linda von Wartburg

The Cochrane Library recently conducted a review of studies to see if NPH is as good as Lantus and Levemir when used as a basal insulin for people with type 2 diabetes. Six studies comparing insulin glargine (Lantus) to NPH (Neutral Protamine Hagedorn) were examined, as well as two studies comparing insulin detemir (Levemir) to NPH.

Duration of the studies, all of which were rated “low” in methodological quality, ranged from 24 to 52 weeks.

The folks at Cochrane concluded that Lantus and Levemir are almost identical to NPH in lowering A1c’s, although Lantus and Levemir are associated with slightly fewer hypoglycemic episodes at night during sleep.

MedPage Today
Cochrane Library



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.